From French Government Insider to AI Disruptor: Why Laurie Soffiati Bet on Nabla After Calling HealthTech 'Ineffective'

As Nabla gains international attention through its close ties to Yann LeCun’s AMI, one of the most ambitious AI research labs, Soffiati joins at a pivotal moment in the shift toward next-generation, agentic healthcare systems.